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Mitochondrial diseases are a group of inherited disorders Caused by a 
derangement of mitochondrial respiration. The clinical manifestations are 
heterogeneous, and the diagnosis is often based on information acquired from 
multiple levels of inquiry that require a variety of diagnostic tests for proper 
determination. 
Neuroimaging may play a significant role in diagnosis. The various modalities 
of nuclear magnetic resonance imaging (MRI) allow for multiple independent 
detection procedures that can give important anatomical and metabolic clues for 
diagnosis when the constellation of symptoms is suggestive of mitochondrial 
disease, neuroimaging features may be diagnostic and suggestive, can help 
direct further workup, and can help to further characterize the underlying 
brain abnormalities. The non-invasive nature of neuroimaging also allows for 
longitudinal studies. To date, no pathognomonic correlation between specific 
genetic defect and neuroimaging findings have been described. The definitive 
diagnosis of a mitochondrial disorder can be difficult to establish. Magnetic 
resonance imaging changes may be nonspecific; however, certain neuroimaging 
results can give important clues that a patient may have a mitochondrial disease. 
Conventional MRI may show Brain atrophy, supratentorial white matter lesions, 
basal ganglia involvement deep gray structural abnormalities, and delayed 
myelination are the most frequent anomalies in the definite cases. 
Also they may represent clearly characteristic of a given disorder such as stroke-
like lesions that do not respect vascular boundaries in mitochondrial myopathy, 
encephalopathy, lactic acidosis, and stroke-like episode (MELAS). White matter 
hyper intensities with or without associated gray matter involvement may also 
be observed or stroke-like lesions that do not respect vascular territories. 
Chemical techniques such as proton magnetic resonance spectroscopy (MRS) 
may demonstrate high levels of lactate or succinate. When found, these results are 
suggestive of a mitochondrial disease. MRI and MRS studies may also show non-
specific findings such as delayed myelination or non-specific leukodystrophies 
picture. However, in the context of other biochemical, structural, and clinical 
findings, even non-specific findings may support further diagnostic testing for 
potential mitochondrial disease. Once a diagnosis has been established, these 
non-invasive tools can also aid in following disease progression and evaluate 
the effects of therapeutic interventions.
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